| Literature DB >> 19752272 |
Andrew J Dalley1, Renae Deans, Jeffrey Lipman, Bala Venkatesh, Michael Rudd, Michael S Roberts, Sheree E Cross.
Abstract
Cephalothin (cefalotin) pharmacokinetics were evaluated for nine severely burned patients (42% +/- 9% mean burn areas) and five healthy volunteers by using non-plasma-protein-bound concentration-time profiles. Burn patients gave increased mean residence times (36%) and reduced total clearances (25%). Mean residence times and distribution volumes increased between 1 and 4 days posttrauma, suggesting that burn patient pharmacokinetics change during the initial fluid resuscitation phase of treatment.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19752272 PMCID: PMC2786355 DOI: 10.1128/AAC.01600-08
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191